Quick Answer
Outlook Therapeutics, Inc. reported Stockholders Equity of -$32.19 million for fiscal year 2025.
Outlook Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$32.19M | +56.0% |
| 2024 | -$73.08M | -406.1% |
| 2023 | -$14.44M | -265.3% |
| 2022 | $8.74M | +89.6% |
| 2021 | $4.61M | +63.0% |
| 2020 | $2.83M | +117.5% |
| 2019 | -$16.13M | +36.9% |
| 2018 | -$25.54M | +24.1% |
| 2017 | -$33.65M | -550.5% |
| 2016 | -$5.17M | +90.5% |
| 2015 | -$54.22M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$38.55M | +23.3% | -19.8% |
| September 30, 2025 | -$32.19M | +56.0% | +13.5% |
| June 30, 2025 | -$37.19M | +55.6% | -14.6% |
| March 31, 2025 | -$32.46M | +75.8% | +35.4% |
| December 31, 2024 | -$50.29M | -106.6% | +31.2% |
| September 30, 2024 | -$73.08M | -406.1% | +12.7% |
| June 30, 2024 | -$83.67M | -1420.6% | +37.7% |
| March 31, 2024 | -$134.24M | -1379.9% | -451.4% |
- Outlook Therapeutics, Inc. showed an increase of +56.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, Outlook Therapeutics, Inc.’s stockholders equity has grown by 40.6% (from -$54.22 million to -$32.19 million).
- The most recent figure is from Outlook Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: